A Greek tragedy: The growing complexity of Alzheimer amyloid precursor protein proteolysis

Journal of Biological Chemistry

Volumn 291, Issue 37, 2016, Pages 19235-19244

  Andrew, Robert J ^a   Kellett, Katherine A B ^b   Thinakaran, Gopal ^a   Hooper, Nigel M ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS; METABOLITES; PROTEOLYSIS;

ALZHEIMER AMYLOID; ALZHEIMER DISEASE; AMYLOID BETAS; AMYLOID PRECURSOR PROTEINS; COMPLEX PICTURES; SECRETASES;

PROTEINS;

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CATHEPSIN B; GAMMA SECRETASE; MEPRIN; MEPRIN BETA; UNCLASSIFIED DRUG; APP PROTEIN, HUMAN; SECRETASE;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LONG TERM POTENTIATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; HUMANS; PROTEOLYSIS;

EID: 84986919826     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R116.746032     Document Type: Review

References (100)

1. Musiek, E. S., and Holtzman, D. M. (2015) Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat. Neurosci. 18, 800- 806
2. Rajendran, L., and Annaert, W. (2012) Membrane trafficking pathways in Alzheimer's disease. Traffic 13, 759-770
3. Takami, M., Nagashima, Y., Sano, Y., Ishihara, S., Morishima-Ka-washima, M., Funamoto, S., and Ihara, Y. (2009) γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment. J. Neurosci. 29, 13042-13052
4. De Strooper, B., and Karran, E. (2016) The cellular phase of Alzheimer's disease. Cell 164, 603-615
5. Jarosz-Griffiths, H. H., Noble, E., Rushworth, J. V., and Hooper, N. M. (2016) Amyloid-β receptors: the good, the bad, and the prion protein. J. Biol. Chem. 291, 3174-3183
6. Belyaev, N. D., Kellett, K. A., Beckett, C., Makova, N. Z., Revett, T. J., Nalivaeva, N. N., Hooper, N. M., and Turner, A. J. (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretasedependent pathway. J. Biol. Chem. 285, 41443- 41454
7. Grimm, M. O., Mett, J., Stahlmann, C. P., Grösgen, S., Haupenthal, V. J., Blümel, T., Hundsdörfer, B., Zimmer, V. C., Mylonas, N. T., Tanila, H., Müller, U., Grimm, H. S., and Hartmann, T. (2015) APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression. Front. Aging Neurosci. 7, 77
8. Multhaup, G., Huber, O., Buée, L., and Galas, M.-C.(2015) Amyloid precursor protein (APP) metabolites APP intracellular fragment (AICD), Aβ42, and Tau in nuclear roles. J. Biol. Chem. 290, 23515-23522
9. Chen, A. C., Kim, S., Shepardson, N., Patel, S., Hong, S., and Selkoe, D. J. (2015) Physical and functional interaction between the α- and γ-secretases: A new model of regulated intramembrane proteolysis. J. Cell Biol. 211, 1157-1176
10. Colombo, A., Wang, H., Kuhn, P. H., Page, R., Kremmer, E., Dempsey, P. J., Crawford, H. C., and Lichtenthaler, S. F. (2013) Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines. Neurobiol. Dis. 49, 137-147
11. Dobrowolska, J. A., Michener, M. S., Wu, G., Patterson, B. W., Chott, R., Ovod, V., Pyatkivskyy, Y., Wildsmith, K. R., Kasten, T., Mathers, P., Dancho, M., Lennox, C., Smith, B. E., Gilberto, D., McLoughlin, D., et al. (2014) CNS amyloid-β, soluble APP-β andβ - kinetics during BACE inhibition. J. Neurosci. 34, 8336- 8346
12. Ben Halima, S., Mishra, S., Raja, K. M., Willem, M., Baici, A., Simons, K., Brüstle, O., Koch, P., Haass, C., Caflisch, A., and Rajendran, L. (2016) Specific inhibition of β-secretase processing of the Alzheimer disease amyloid precursor protein. Cell Rep. 14, 2127-2141
13. Lichtenthaler, S. F. (2011) α-Secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J. Neurochem. 116, 10-21
14. Saftig, P., and Reiss, K. (2011) The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90, 527-535
15. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., Flamez, P., Dequenne, A., Godaux, E., van Leuven, F., and Fahrenholz, F. (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456-1464
16. Tippmann, F., Hundt, J., Schneider, A., Endres, K., and Fahrenholz, F. (2009) Up-regulation of the α-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 23, 1643-1654
17. Endres, K., Fahrenholz, F., Lotz, J., Hiemke, C., Teipel, S., Lieb, K., Tüscher, O., and Fellgiebel, A. (2014) Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin. Neurology 83, 1930-1935
18. Nhan, H. S., Chiang, K., and Koo, E. H. (2015) The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathol. 129, 1-19
19. Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I. S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J. Z., Cheng, L., Sun, Y. E., Yu, S. P., Levey, A. I., and Ye, K. (2014) Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nat. Med. 20, 1254-1262
20. Zhang, Z., Song, M., Liu, X., Su Kang, S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Ping Yu, S., Jia, J., Levey, A. I., and Ye, K. (2015)δ-Secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease. Nat. Commun. 6, 8762
21. Simons, M., de Strooper, B., Multhaup, G., Tienari, P. J., Dotti, C. G., and Beyreuther, K. (1996) Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16, 899-908
22. Baranger, K., Marchalant, Y., Bonnet, A. E., Crouzin, N., Carrete, A., Paumier, J. M., Py, N. A., Bernard, A., Bauer, C., Charrat, E., Moschke, K., Seiki, M., Vignes, M., Lichtenthaler, S. F., Checler, F., et al. (2016) MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. Cell. Mol. Life Sci. 73, 217-236
23. Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D., Moore, S., Daria, A., Hampel, H., Müller, V., Giudici, C., Nuscher, B., Wenninger-Weinzierl, A., et al. (2015) η-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526, 443- 447
24. Hernandez-Guillamon, M., Mawhirt, S., Blais, S., Montaner, J., Neubert, T. A., Rostagno, A., and Ghiso, J. (2015) Sequential amyloid-β degradation by the matrix metalloproteases MMP-2 and MMP-9. J. Biol. Chem. 290, 15078-15091
25. Fragkouli, A., Tsilibary, E. C., and Tzinia, A. K. (2014) Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice. Neurobiol. Dis. 70, 179-189
26. Bien, J., Jefferson, T., Causević, M., Jumpertz, T., Munter, L., Multhaup, G., Weggen, S., Becker-Pauly, C., and Pietrzik, C. U. (2012) The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species. J. Biol. Chem. 287, 33304-33313
27. Schönherr, C., Bien, J., Isbert, S., Wichert, R., Prox, J., Altmeppen, H., Kumar, S., Walter, J., Lichtenthaler, S. F., Weggen, S., Glatzel, M., Becker-Pauly, C., and Pietrzik, C. U. (2016) Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site. Mol. Neurodegener. 11, 19
28. Jefferson, T., Čauševič, M., auf dem Keller, U., Schilling, O., Isbert, S., Geyer, R., Maier, W., Tschickardt, S., Jumpertz, T., Weggen, S., Bond, J. S., Overall, C. M., Pietrzik, C. U., and Becker-Pauly, C. (2011) Metalloprotease meprin β generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J. Biol. Chem. 286, 27741-27750
29. Portelius, E., Brinkmalm, G., Tran, A., Andreasson, U., Zetterberg, H., Westman-Brinkmalm, A., Blennow, K., and Ohrfelt, A. (2010) Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Exp. Neurol. 223, 351-358
30. Jäckle, F., Schmidt, F., Wichert, R., Arnold, P., Prox, J., Mangold, M., Ohler, A., Pietrzik, C. U., Koudelka, T., Tholey, A., Gütschow, M., Stirnberg, M., and Becker-Pauly, C. (2015) Metalloprotease meprin β is activated by transmembrane serine protease matriptase-2 at the cell surface thereby enhancing APP shedding. Biochem. J. 470, 91-103
31. Vella, L. J., and Cappai, R. (2012) Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments. FASEB J. 26, 2930-2940
32. Olsen, O., Kallop, D. Y., McLaughlin, T., Huntwork-Rodriguez, S., Wu, Z., Duggan, C. D., Simon, D. J., Lu, Y., Easley-Neal, C., Takeda, K., Hass, P. E., Jaworski, A., O'Leary, D. D., Weimer, R. M., and Tessier-Lavigne, M. (2014) Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of β-secretase. J. Neurosci. 34, 6438-6447
33. Nikolaev, A., McLaughlin, T., O'Leary, D. D., and Tessier-Lavigne, M. (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989
34. Hook, G., Yu, J., Toneff, T., Kindy, M., and Hook, V. (2014) Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J. Alzheimers Dis. 41, 129-149
35. Sun, B., Zhou, Y., Halabisky, B., Lo, I., Cho, S.-H, Mueller-Steiner, S., Devidze, N., Wang, X., Grubb, A., and Gan, L. (2008) Cystatin C-cathepsin B axis regulates amyloid β levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60, 247-257
36. Hook, V. Y., Kindy, M., and Hook, G. (2008) Inhibitors of cathepsin B improve memory and reduce β-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, β-secretase site of the amyloid precursor protein. J. Biol. Chem. 283, 7745-7753
37. Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., and Vassar, R. (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease. Acta Neuropathol. 132, 235-256
38. Gowrishankar, S., Yuan, P., Wu, Y., Schrag, M., Paradise, S., Grutzendler, J., De Camilli, P., and Ferguson, S. M. (2015) Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques. Proc. Natl. Acad. Sci. U. S. A. 112, E3699-E3708
39. Schilling, S., Lauber, T., Schaupp, M., Manhart, S., Scheel, E., Böhm, G., and Demuth, H. U. (2006) On the seeding and oligomerization of pGluamyloid peptides (in vitro). Biochemistry 45, 12393-12399
40. Nussbaum, J. M., Schilling, S., Cynis, H., Silva, A., Swanson, E., Wangsanut, T., Tayler, K., Wiltgen, B., Hatami, A., Rönicke, R., Reymann, K., Hutter-Paier, B., Alexandru, A., Jagla, W., Graubner, S., et al. (2012)Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 485, 651-655
41. Deng, Y., Wang, Z., Wang, R., Zhang, X., Zhang, S., Wu, Y., Staufenbiel, M., Cai, F., and Song, W. (2013) Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Eur. J. Neurosci. 37, 1962-1969
42. Portelius, E., Lashley, T., Westerlund, A., Persson, R., Fox, N. C., Blennow, K., Revesz, T., and Zetterberg, H. (2015) Brain amyloid-β fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Neurodegener. Dis. 15, 50-57
43. Frost, J. L., Liu, B., Rahfeld, J.-U., Kleinschmidt, M., O'Nuallain, B., Le, K. X., Lues, I., Caldarone, B. J., Schilling, S., Demuth, H.-U., and Lemere, C. A. (2015) An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1βE9 mice. Neurobiol. Aging 36, 3187-3199
44. Portelius, E., Mattsson, N., Andreasson, U., Blennow, K., and Zetterberg, H. (2011) Novel Aβ isoforms in Alzheimer's disease: their role in diagnosis and treatment. Curr. Pharm. Des. 17, 2594-2602
45. Welzel, A. T., Maggio, J. E., Shankar, G. M., Walker, D. E., Ostaszewski, B. L., Li, S., Klyubin, I., Rowan, M. J., Seubert, P., Walsh, D. M., and Selkoe, D. J. (2014) Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity. Biochemistry 53, 3908-3921
46. Bayer, T. A., and Wirths, O. (2014) Focusing the amyloid cascade hypothesis on N-truncated Aβ peptides as drug targets against Alzheimer's disease. Acta Neuropathol. 127, 787- 801
47. Portelius, E., Dean, R. A., Andreasson, U., Mattsson, N., Westerlund, A., Olsson, M., Demattos, R. B., Racke, M. M., Zetterberg, H., May, P. C., and Blennow, K. (2014) β-Site amyloid precursor protein-cleaving enzyme 1 (BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. Alzheimers Res. Ther. 6, 75
48. Haapasalo, A., and Kovacs, D. M. (2011) The many substrates of presenilin/γ-secretase. J. Alzheimers Dis. 25, 3-28
49. Vassar, R. (2014) BACE1 inhibitor drugs in clinical trials for Alzheimer's disease. Alzheimers Res. Ther. 6, 89
50. Matsuda, S., Giliberto, L., Matsuda, Y., McGowan, E. M., and D'Adamio, L. (2008) BRI2 inhibits amyloid β-peptide precursor protein processing by interfering with the docking of secretases to the substrate. J. Neurosci. 28, 8668- 8676
51. Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A., Breiderhoff, T., Jansen, P., Wu, X., Bales, K. R., Cappai, R., Masters, C. L., Gliemann, J., Mufson, E. J., et al. (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 102, 13461-13466
52. McLoughlin, D. M., and Miller, C. C. (2008) The FE65 proteins and Alzheimer's disease. J. Neurosci. Res. 86, 744-754
53. Ho, A., Liu, X., and Südhof, T. C. (2008) Deletion of Mint proteins decreases amyloid production in transgenic mouse models of Alzheimer's disease. J. Neurosci. 28, 14392-14400
54. Matsuda, S., Tamayev, R., and D'Adamio, L. (2011) Increased AβPP processing in familial Danish dementia patients. J. Alzheimers Dis. 27, 385-391
55. Gautam, V., D'Avanzo, C., Berezovska, O., Tanzi, R. E., and Kovacs, D. M. (2015) Synaptotagmins interact with APP and promote Aβ generation. Mol. Neurodegener. 10, 31
56. Hosp, F., Vossfeldt, H., Heinig, M., Vasiljevic, D., Arumughan, A., Wyler, E., Genetic and Environmental Risk for Alzheimer's Disease GERAD1 Consortium, Landthaler, M., Hubner, N., Wanker, E. E., Lannfelt, L., Ingelsson, M., Lalowski, M., Voigt, A., and Selbach, M. (2015) Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Rep. 11, 1134-1146
57. Inoue, M., Hur, J. Y., Kihara, T., Teranishi, Y., Yamamoto, N. G., Ishikawa, T., Wiehager, B., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S. (2015) Human brain proteins showing neuron-specific interactions with γ-secretase. FEBS J. 282, 2587-2599
58. Bai, Y., Markham, K., Chen, F., Weerasekera, R., Watts, J., Horne, P., Wakutani, Y., Bagshaw, R., Mathews, P. M., Fraser, P. E., Westaway, D., St George-Hyslop, P., and Schmitt-Ulms, G. (2008) The in vivo brain interactome of the amyloid precursor protein. Mol. Cell. Proteomics 7, 15-34
59. Rice, H. C., Young-Pearse, T. L., and Selkoe, D. J. (2013) Systematic evaluation of candidate ligands regulating ectodomain shedding of amyloid precursor protein. Biochemistry 52, 3264-3277
60. Kohli, B. M., Pflieger, D., Mueller, L. N., Carbonetti, G., Aebersold, R., Nitsch, R. M., and Konietzko, U. (2012) Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J. Proteome Res. 11, 4075-4090
61. Cottrell, B. A., Galvan, V., Banwait, S., Gorostiza, O., Lombardo, C. R., Williams, T., Schilling, B., Peel, A., Gibson, B., Koo, E. H., Link, C. D., and Bredesen, D. E. (2005) A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Ann. Neurol. 58, 277-289
62. Mecozzi, V. J., Berman, D. E., Simoes, S., Vetanovetz, C., Awal, M. R., Patel, V. M., Schneider, R. T., Petsko, G. A., Ringe, D., and Small, S. A. (2014) Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 10, 443- 449
63. So, P. P., Zeldich, E., Seyb, K. I., Huang, M. M., Concannon, J. B., King, G. D., Chen, C. D., Cuny, G. D., Glicksman, M. A., and Abraham, C. R. (2012) Lowering of amyloid β peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization. Am. J. Neurodegener. Dis. 1, 75-87
64. Pasciuto, E., Ahmed, T., Wahle, T., Gardoni, F., D'Andrea, L., Pacini, L., Jacquemont, S., Tassone, F., Balschun, D., Dotti, C. G., Callaerts-Vegh, Z., D'Hooge, R., Müller, U. C., Di Luca, M., De Strooper, B., and Bagni, C. (2015) Dysregulated ADAM10-mediated processing of APP during a critical time window leads to synaptic deficits in fragile X syndrome. Neuron 87, 382-398
65. Freude, K. K., Penjwini, M., Davis, J. L., LaFerla, F. M., and Blurton-Jones, M. (2011) Soluble amyloid precursor protein induces rapid neural differentiation of human embryonic stem cells. J. Biol. Chem. 286, 24264-24274
66. Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M., and Mattson, M. P. (1996) Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896
67. Lauritzen, I., Pardossi-Piquard, R., Bauer, C., Brigham, E., Abraham, J. D., Ranaldi, S., Fraser, P., St-George-Hyslop, P., Le Thuc, O., Espin, V., Chami, L., Dunys, J., and Checler, F. (2012) The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J. Neurosci. 32, 16243-16255a
68. Tamayev, R., Matsuda, S., Arancio, O., and D'Adamio, L. (2012) β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol. Med. 4, 171-179
69. Mitani, Y., Yarimizu, J., Saita, K., Uchino, H., Akashiba, H., Shitaka, Y., Ni, K., and Matsuoka, N. (2012) Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid pre-cursor protein-transgenic and nontransgenic mice. J. Neurosci. 32, 2037-2050
70. Bittner, T., Fuhrmann, M., Burgold, S., Jung, C. K., Volbracht, C., Steiner, H., Mitteregger, G., Kretzschmar, H. A., Haass, C., and Herms, J. (2009) γ-Secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J. Neurosci. 29, 10405-10409
71. Milosch, N., Tanriöver, G., Kundu, A., Rami, A., François, J. C., Baumkötter, F., Weyer, S. W., Samanta, A., Jäschke, A., Brod, F., Buchholz, C. J., Kins, S., Behl, C., Müller, U. C., and Kögel, D. (2014) Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway. Cell Death Dis. 5, e1391
72. Corrigan, F., Vink, R., Blumbergs, P. C., Masters, C. L., Cappai, R., and van den Heuvel, C. (2012) sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. J. Neurochem. 122, 208-220
73. Fol, R., Braudeau, J., Ludewig, S., Abel, T., Weyer, S. W., Roederer, J. P., Brod, F., Audrain, M., Bemelmans, A. P., Buchholz, C. J., Korte, M., Cartier, N., and Müller, U. C. (2016) Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model. Acta Neuropathol. 131, 247-266
74. Hick, M., Herrmann, U., Weyer, S. W., Mallm, J. P., Tschäpe, J. A., Borgers, M., Mercken, M., Roth, F. C., Draguhn, A., Slomianka, L., Wolfer, D. P., Korte, M., and Müller, U. C. (2015) Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity. Acta Neuropathol. 129, 21-37
75. Tian, Y., Crump, C. J., and Li, Y. M. (2010) Dual role of α-secretase cleavage in the regulation of γ-secretase activity for amyloid production. J. Biol. Chem. 285, 32549-32556
76. Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., and Ball, M. J. (1994) Chemical characterization of Aβ17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269, 10987-10990
77. Dulin, F., Léveillé, F., Ortega, J. B., Mornon, J. P., Buisson, A., Callebaut, I., and Colloc'h, N. (2008) P3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers. FEBS Lett. 582, 1865-1870
78. Jang, H., Arce, F. T., Ramachandran, S., Capone, R., Azimova, R., Kagan, B. L., Nussinov, R., and Lal, R. (2010) Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 107, 6538- 6543
79. Beckett, C., Nalivaeva, N. N., Belyaev, N. D., and Turner, A. J. (2012) Nuclear signalling by membrane protein intracellular domains: the AICD enigma. Cell. Signal. 24, 402-409
80. Ghosal, K., Vogt, D. L., Liang, M., Shen, Y., Lamb, B. T., and Pimplikar, S. W. (2009) Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl. Acad. Sci. U. S. A. 106, 18367-18372
81. Giliberto, L., d'Abramo, C., Acker, C. M., Davies, P., and D'Adamio, L. (2010) Transgenic expression of the amyloid-β precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivo. PLoS ONE 5, e11609
82. Dawkins, E., Gasperini, R., Hu, Y., Cui, H., Vincent, A. J., Bolós, M., Young, K. M., Foa, L., and Small, D. H. (2014) The N-terminal fragment of the β-amyloid precursor protein of Alzheimer's disease (N-APP) binds to phosphoinositide-rich domains on the surface of hippocampal neurons. J. Neurosci. Res. 92, 1478-1489
83. Burgos, P. V., Mardones, G. A., Rojas, A. L., daSilva, L. L., Prabhu, Y., Hurley, J. H., and Bonifacino, J. S. (2010) Sorting of the Alzheimer's disease amyloid precursor protein mediated by the AP-4 complex. Dev. Cell 18, 425-436
84. Matsuda, S., Matsuda, Y., and D'Adamio, L. (2009) BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2. J. Biol. Chem. 284, 15815-15825
85. Matsuda, S., Matsuda, Y., and D'Adamio, L. (2009) CD74 interacts with APP and suppresses the production of Aβ. Mol. Neurodegener. 4, 41
86. Lee, J., Retamal, C., Cuitiño, L., Caruano-Yzermans, A., Shin, J. E., van Kerkhof, P., Marzolo, M. P., and Bu, G. (2008) Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes. J. Biol. Chem. 283, 11501-11508
87. Yang, Y., Turner, R. S., and Gaut, J. R. (1998) The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion. J. Biol. Chem. 273, 25552-25555
88. Ulery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T., and Strickland, D. K. (2000) Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP): evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J. Biol. Chem. 275, 7410-7415
89. Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., and Strickland, D. K. (1995) LDL receptorrelated protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340
90. Cam, J. A., Zerbinatti, C. V., Knisely, J. M., Hecimovic, S., Li, Y., and Bu, G. (2004) The low density lipoprotein receptor-related protein 1B retains β-amyloid precursor protein at the cell surface and reduces amyloid-β peptide production. J. Biol. Chem. 279, 29639-29646
91. Brodeur, J., Thériault, C., Lessard-Beaudoin, M., Marcil, A., Dahan, S., and Lavoie, C. (2012) LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer's disease. Mol. Neurodegener. 7, 31
92. Park, J. H., Gimbel, D. A., GrandPre, T., Lee, J. K., Kim, J. E., Li, W., Lee, D. H., and Strittmatter, S. M. (2006) Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-β plaque deposition. J. Neurosci. 26, 1386-1395
93. Zhou, X., Hu, X., He, W., Tang, X., Shi, Q., Zhang, Z., and Yan, R. (2011) Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition. FASEB J. 25, 3146-3156
94. Kuan, Y.-H., Gruebl, T., Soba, P., Eggert, S., Nesic, I., Back, S., Kirsch, J., Beyreuther, K., and Kins, S. (2006) PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2. J. Biol. Chem. 281, 40114- 40123
95. Akiyama, H., Shin, R. W., Uchida, C., Kitamoto, T., and Uchida, T. (2005) Pin1 promotes production of Alzheimer's amyloid β from β-cleaved amyloid precursor protein. Biochem. Biophys. Res. Commun. 336, 521-529
96. Pastorino, L., Sun, A., Lu P-J, Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., Xia, W., Nicholson, L. K., and Lu, K. P. (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 440, 528-534
97. Reitz, C., Tokuhiro, S., Clark, L. N., Conrad, C., Vonsattel, J. P., Hazrati, L. N., Palotás, A., Lantigua, R., Medrano, M., Z Jiménez-Velázquez, I., Vardarajan, B., Simkin, I., Haines, J. L., Pericak-Vance, M. A., Farrer, L. A., et al. (2011) SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann. Neurol. 69, 47-64
98. Andersen, O. M., Schmidt, V., Spoelgen, R., Gliemann, J., Behlke, J., Galatis, D., McKinstry, W. J., Parker, M. W., Masters, C. L., Hyman, B. T., Cappai, R., and Willnow, T. E. (2006) Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. Biochemistry 45, 2618-2628
99. Ho, A., and Südhof, T. C. (2004) Binding of F-spondin to amyloid-β precursor protein: a candidate amyloid-β precursor protein ligand that modulates amyloid-β precursor protein cleavage. Proc. Natl. Acad. Sci. U.S.A. 101, 2548-2553
100. Wang, J., Lu, R., Yang, J., Li, H., He, Z., Jing, N., Wang, X., and Wang, Y. (2015) TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production. Nat. Commun. 6, 8876